Briët JM - Search Results

1

Free thyroxine levels during the first weeks of life and neurodevelopmental outcome until the age of 5 years in very preterm infants.

van Wassenaer AG, Briët JM, van Baar A, Smit BJ, Tamminga P, de Vijlder JJ, Kok JH. van Wassenaer AG, et al. Among authors: briet jm. Pediatrics. 2002 Sep;110(3):534-9. doi: 10.1542/peds.110.3.534. Pediatrics. 2002. PMID: 12205256 Clinical Trial.

2

Neurodevelopmental outcome of children treated with antenatal thyrotropin-releasing hormone.

Briët JM, van Sonderen L, Buimer M, Boer K, Kok JH. Briët JM, et al. Pediatrics. 2002 Aug;110(2 Pt 1):249-53. doi: 10.1542/peds.110.2.249. Pediatrics. 2002. PMID: 12165574 Clinical Trial.

3

The discrepancy between maturation of visual-evoked potentials and cognitive outcome at five years in very preterm infants with and without hemodynamic signs of fetal brain-sparing.

Scherjon S, Briët J, Oosting H, Kok J. Scherjon S, et al. Pediatrics. 2000 Feb;105(2):385-91. doi: 10.1542/peds.105.2.385. Pediatrics. 2000. PMID: 10654960

4

Effects of thyroxine supplementation on neurologic development in infants born at less than 30 weeks' gestation.

van Wassenaer AG, Kok JH, de Vijlder JJ, Briët JM, Smit BJ, Tamminga P, van Baar A, Dekker FW, Vulsma T. van Wassenaer AG, et al. Among authors: briet jm. N Engl J Med. 1997 Jan 2;336(1):21-6. doi: 10.1056/NEJM199701023360104. N Engl J Med. 1997. PMID: 8970936 Free article. Clinical Trial.

5

Thyroid function in preterm newborns; is T4 treatment required in infants < 27 weeks' gestational age?

Van Wassenaer AG, Kok JH, Briët JM, van Baar AL, de Vijlder JJ. Van Wassenaer AG, et al. Among authors: briet jm. Exp Clin Endocrinol Diabetes. 1997;105 Suppl 4:12-8. doi: 10.1055/s-0029-1211925. Exp Clin Endocrinol Diabetes. 1997. PMID: 9439908 Clinical Trial.

6

Thyroid function in very preterm newborns: possible implications.

Van Wassenaer AG, Kok JH, Briët JM, Pijning AM, de Vijlder JJ. Van Wassenaer AG, et al. Among authors: briet jm. Thyroid. 1999 Jan;9(1):85-91. doi: 10.1089/thy.1999.9.85. Thyroid. 1999. PMID: 10037082 Clinical Trial.

7

Evaluation of the effect of thyroxine supplementation on behavioural outcome in very preterm infants.

Briët JM, van Wassenaer AG, van Baar A, Dekker FW, Kok JH. Briët JM, et al. Dev Med Child Neurol. 1999 Feb;41(2):87-93. doi: 10.1017/s0012162299000195. Dev Med Child Neurol. 1999. PMID: 10075094 Free article. Clinical Trial.

8

Neonatal thyroxine supplementation in very preterm children: developmental outcome evaluated at early school age.

Briët JM, van Wassenaer AG, Dekker FW, de Vijlder JJ, van Baar A, Kok JH. Briët JM, et al. Pediatrics. 2001 Apr;107(4):712-8. doi: 10.1542/peds.107.4.712. Pediatrics. 2001. PMID: 11335749 Clinical Trial.

9

Postnatal thyroid hormone replacement in very preterm infants.

Kok JH, Briet JM, van Wassenaer AG. Kok JH, et al. Among authors: briet jm. Semin Perinatol. 2001 Dec;25(6):417-25. doi: 10.1053/sper.2001.27550. Semin Perinatol. 2001. PMID: 11778912 Review.

10

Very preterm birth is associated with disabilities in multiple developmental domains.

van Baar AL, van Wassenaer AG, Briët JM, Dekker FW, Kok JH. van Baar AL, et al. Among authors: briet jm. J Pediatr Psychol. 2005 Apr-May;30(3):247-55. doi: 10.1093/jpepsy/jsi035. Epub 2005 Feb 23. J Pediatr Psychol. 2005. PMID: 15784921

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters